+49(0)2233 923749 contact@klaasconsulting.com
Kundensegmentierung in Deutschland

Kundensegmentierung in Deutschland

April 2022 Warum ist eine gute Kundensegmentierung in Deutschland wichtig? Eine gute Kundensegmentierung in Deutschland ist entscheidend für den Markteintrittserfolg.

Lt. dem Bundesministerium gibt es in Deutschland ca. 400.000 verschiedene Medizinprodukte. Das sind Diagnostische Geräte, Produkte für die Chirurgie, Intensivmedizin, Implantate, Produkte zur Sterilisation aber auch Abdeckungen und Hilfsmittel verschiedener Art oder chirurgische Materialien und Labordiagnostik, u.v.m.

Diese Produkte finden sich in verschiedenen Kundensegmenten wieder – zum Verbrauch/im Einsatz, im Verkauf/in der Vermietung, zur Empfehlung/ Verschreibung. Kundensegmentierungen hängen stark von der Produktpositionierung ab. Diese kann im Vergleich zu den Mitbewerbern gänzlich anders aussehen; der Hersteller kann sich sogar hiermit von seinen Mitbewerbern differenzieren.

Beispielsweise würde sich ein Hersteller im Diabetesbereich klassisch auf die Kundengruppierungen der Diabetologen als Verschreiber der Teststreifen und auf das Segment der Apotheker/innen für den Verkauf der Teststreifen konzentrieren. Durch eine andere Produktpositionierung, z.B. Freiverkauf der Teststreifen und Geräte, würden die Drogeriemärkte oder sogar die Supermärkte als Kundengruppe für den Verkauf im Vordergrund stehen.

Download zum gesamten Artikel

Veröffentlich in der Februarausgabe 2022 der Fachzeitschrift MTD (MTD-Verlag); www.mtd.de © MTD-Verlag

Falls Sie auch den Markteintritt in Deutschland planen, kontaktieren Sie uns bitte.

Bitte lesen Sie auch die folgenden Artikel:

Effizienzsteigerung des strategischen Vertriebs von Medizinprodukten in Europa für KMU’s“

Kundensegmentierung in Deutschland

Market Segmentation in Germany

Market Segmentation in Germany as a Key Success Factor for Market Entry

July 2021 – Market Segmentation in Germany – According to the Federal Ministry of Health, there are about 400,000 different medical devices in Germany. These are diagnostic devices, products for surgery, intensive care, implants, products for sterilisation but also covers and medical aids of various kinds or surgical materials and laboratory diagnostics, and many more.

(more…)
MRA between Switzerland and the EU

MRA between Switzerland and the EU

MRA: Switzerland is preparing a worst-case-szenario

April 2021 – MRA between Switzerland and the EU has to be updated. The new MDR has implications for the market introduction of medical devices in Switzerland.

(more…)
Market Barriers in Germany for Medical Devices

Market Barriers in Germany for Medical Devices

Market Barriers to the introduction of medical devices in Germany. What could these be and how can they be overcome?

Market barriers to market entry to Germany for Medical Device Manufacturers
photo: iStock
Market barriers to market entry in Germany for Medical Device Manufacturers

December 2020, Maria Klaas – According to a recent study from 2020 by Clairfield International, the German medical technology market is by far the largest in Europe with € 33 billion. It is therefore no wonder that small and medium-sized enterprises (SMEs) from Germany or abroad want to participate in this market. 

(more…)
The global market for medical technology companies

The global market for medical technology companies

The global market for medical technology companies – facts and figures

Juli 2020 – The global market for medical technology continues to offer great market opportunities for medical technology companies. Especially in the Middle East and Asia, the markets are growing steadily and rapidly. South America is recording double-digit growth rates, mainly due to the Mercosur free trade agreement concluded in 2019. Germany still plays the most important role in Europe. The per capita turnover is 402€, more than in any other country in the world.

CountryWorld Market ShareMarket Volume Per capita sales
North America39 %174.0 bn.301 €
Europe27 %160.0 bn.160 €
Germany  7 % 33.0 bn.402 €
Asien26 %115.0 bn. 26 €
Russia  1 %   4.2 bn. 30 €
Brazil  1 %   5.5 bn. 27 €
Rest of the world  7 %30.0 bn. 20 €
Market study medical technology 2020 by Clairfield International

Europe:

  • There are 27,000 medtech companies in Europe, about half of which are based in Germany, followed by the UK, Ireland, Italy, Switzerland, Spain and France. Most of them are SMEs.
  • 650,000 people work for medical technology companies in Europe, of which about 210,000 people are in Germany alone
  • Two of the world’s top-selling companies are based in Germany: Siemens Healthineers and Fresenius Medical Care. Three others are among the top 10 in Europe. These are Philipps in the Netherlands and Novartis and Roche in Switzerland

North America:

  • North America is the largest market for medical technology
  • Seven of the ten top-selling medical technology companies come from the USA
  • 6,500 small and medium-sized MedTech companies are located in the USA
  • Approximately 520,000 people are employed by medical technology companies in the USA
  • The main hubs are located in California, Minnesota, Massachusetts. Florida, Indiana, Pennsylvania, Texas, New York, New Jersey and Illinois also play an important role

Asia:

  • Asia is the third largest market after North America and Europe. Market researchers assume that Asia will overtake Europe in 2020.
  • The main reason for the rapid growth in Asia is the growing middle class and the rising average age. This is expected to rise to around 600 million people by 2025.
  • Various funding programmes are providing massive support for technical developments in Asian countries, for example in Singapore and China.

Rest of the world:

  • Asia, Latin America and the Middle East show the greatest growth potential for medical products
  • The MedTech market is growing enormously, especially in the Middle East
  • Double-digit growth rates are predicted in emerging markets such as Mexico, Malaysia and Brazil
  • Brazil is one of the fastest growing markets in the world. In recent years, imports have grown by around 26% annually. This can be explained by the free trade agreement Mercosur, which was concluded in 2019 and will continue to facilitate the export of MedTech products to South America.

Source: Marktstudie Medizintechnik 2020, Luther.Clairfield International

Are you looking for strategic sales partners in the medical technology sector? Please contact us!

Read also: Efficiency increase of the strategic distribution of medical devices in Europe for SMEs